These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Redefining efficacy of antihypertensive therapies beyond blood pressure reduction--the role of angiotensin II antagonists. Conlin PR Int J Clin Pract; 2005 Feb; 59(2):214-24. PubMed ID: 15854200 [TBL] [Abstract][Full Text] [Related]
23. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. Zanchetti A; Grassi G; Mancia G J Hypertens; 2009 May; 27(5):923-34. PubMed ID: 19381107 [TBL] [Abstract][Full Text] [Related]
24. [Threshold and target blood pressures for treating hypertension. The facts]. Holzgreve H MMW Fortschr Med; 2005 Apr; 147(15):45-6. PubMed ID: 15884503 [No Abstract] [Full Text] [Related]
25. [170 before breakfast already. Here the therapy is not right!]. Schmieder R MMW Fortschr Med; 2005 Feb; 147(8):60-1. PubMed ID: 18441568 [No Abstract] [Full Text] [Related]
26. Reply to Vardan et al's "Importance of intraarterial blood pressure measurement in the evaluation of a new antihypertensive agent and the need to define hypertension also by this method". O'Brien E; O'Malley K Am J Hypertens; 1991 Jul; 4(7 Pt 1):642-3. PubMed ID: 1873022 [No Abstract] [Full Text] [Related]
27. [Therapy of hypertension with a beta-receptor-antagonist]. Dorph S; Binder C Ugeskr Laeger; 1968 Nov; 130(48):2056-60. PubMed ID: 5707924 [No Abstract] [Full Text] [Related]
28. Blood pressure categories and cardiovascular risk factors in Japan: the Jichi Medical School (JMS) Cohort Study. Ishikawa S; Shibano Y; Asai Y; Kario K; Kayaba K; Kajii E Hypertens Res; 2007 Jul; 30(7):643-9. PubMed ID: 17785933 [TBL] [Abstract][Full Text] [Related]
31. Current treatment of hypertension. Vidt DG Minerva Med; 2001 Aug; 92(4):213-25. PubMed ID: 11535966 [TBL] [Abstract][Full Text] [Related]
32. [Lowering blood pressure in obese hypertensive patients. Which antihypertensive drugs are suitable]. Pischon T; Sharma AM MMW Fortschr Med; 2001 Nov; 143(48):34-8. PubMed ID: 11770373 [TBL] [Abstract][Full Text] [Related]
33. Intensive blood pressure treatment: beneficial for all but the smoking hypertensives? Lund-Johansen P J Hypertens; 2003 Apr; 21(4):697-700. PubMed ID: 12658013 [No Abstract] [Full Text] [Related]
34. [Experiences with a new hypotensive substance]. Kühns K; Janocha U; Janocha C; Magnus D Munch Med Wochenschr; 1965 Dec; 107(51):2599-602. PubMed ID: 5331065 [No Abstract] [Full Text] [Related]
35. [Our point of view. Trough to peak ratio of antihypertensive drugs: methodologic issues and clinical implications]. Polónia J Rev Port Cardiol; 1996 Apr; 15(4):281-92. PubMed ID: 8814671 [No Abstract] [Full Text] [Related]
36. Lessons from recent hypertension trials: how low to lower blood pressure. Gifford RW South Med J; 2000 May; 93(5):528-30. PubMed ID: 10832958 [No Abstract] [Full Text] [Related]
37. [Hypertension as a function of age]. Gensini GF; Corradi F Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125 [TBL] [Abstract][Full Text] [Related]
38. Reduction of blood pressure variability: a new strategy for the treatment of hypertension. Su DF; Miao CY Trends Pharmacol Sci; 2005 Aug; 26(8):388-90. PubMed ID: 15990175 [TBL] [Abstract][Full Text] [Related]
39. [Benefits of hypertension treatment in the elderly]. Girerd X; Hanon O Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):518-22. PubMed ID: 12555376 [TBL] [Abstract][Full Text] [Related]